Page last updated: 2024-11-04

salmeterol xinafoate and Asthenia

salmeterol xinafoate has been researched along with Asthenia in 1 studies

salmeterol : A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation.
2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol : A phenol having a hydroxymethyl group at C-2 and a 1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl group at C-4; derivative of phenylethanolamine.

Asthenia: Clinical sign or symptom manifested as debility, or lack or loss of strength and energy.

Research Excerpts

ExcerptRelevanceReference
" It had lower oral absorption and bioavailability than salmeterol in both rat and dog."1.37The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group. ( Barrett, VJ; Ford, AJ; Looker, BE; Lunniss, GE; Needham, D; Procopiou, PA; Smith, CE; Somers, G, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Procopiou, PA1
Barrett, VJ1
Ford, AJ1
Looker, BE1
Lunniss, GE1
Needham, D1
Smith, CE1
Somers, G1

Other Studies

1 other study available for salmeterol xinafoate and Asthenia

ArticleYear
The discovery of long-acting saligenin β₂ adrenergic receptor agonists incorporating a urea group.
    Bioorganic & medicinal chemistry, 2011, Oct-15, Volume: 19, Issue:20

    Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Asthenia; Bronchodilator Agents; CHO Cells;

2011